查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2146877

人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：全球市場預測，2026-2032 年

Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場將成長至 4.9112 億美元，複合年成長率為 10.43%。

主要市場統計數據
基準年 2025 2.4512億美元
預計年份：2026年 2.7011億美元
預測年份 2032 4.9112億美元
複合年成長率 (%) 10.43%

人類 EGFR、KRAS、BRAF、PIK3CA、ALK 和 ROS1 基因突變檢測試劑盒有助於腫瘤的分子分型，並為基於生物標記的臨床決策提供基礎。這些試劑盒的重要性在腫瘤學領域尤其突出，因為治療方案的選擇、抗藥性評估和診斷確認都依賴於識別具有治療意義的基因組突變。試劑盒的普及應用受多種因素影響，例如分析性能、檢體品質、工作流程整合、監管要求、保險報銷以及訓練有素的實驗室技術人員的可用性。

精準腫瘤診斷的變革性變化

診斷方法正從單基因檢測轉向多基因檢測和序貫檢測策略，以提高組織利用效率並擴大生物標記覆蓋範圍。檢查室也在優先考慮可重複性、週轉時間、品質保證以及與現有平台的兼容性，同時平衡基於組織的檢測和液態生物檢體方法。隨著癌症治療朝著更個體化的路徑發展，與伴隨診斷的合作、分散式檢查以及對複雜突變結果更清晰的解讀變得日益重要。

利用人工智慧 (AI) 提高解讀效率和工作流程效率

人工智慧 (AI) 可以透過輔助影像和訊號解讀、識別品管異常、確定突變優先順序以及幫助檢查室管理工作流程資料來改善這一領域。其價值取決於具有代表性的檢驗資料集、透明的效能指標、人工監督、網路安全以及對適用醫療設備要求的合規性。人工智慧應該「補充」而非「取代」檢查室專家，尤其是在結果存在技術上的模糊性或具有重大治療意義的情況下。

對全球診斷系統的區域性見解

在北美，不同地區的分子檢測服務取得和保險報銷情況各不相同，但總體而言，這些地區擁有先進的分子檢測設施、成熟的腫瘤網路和結構化的生物標記檢測流程。在歐洲，強大的研究能力與各國特有的監管和資金籌措環境結合。亞太地區已建立起完善的檢測體系，但檢測需求正在迅速成長，基礎設施和人才水準也因市場而異。在拉丁美洲，專業檢測服務的可近性仍然不穩定，許多機構依賴轉診網路。在中東，集中式和醫院式分子診斷能力正在發展，但在非洲，分子檢測的普及取決於檢查室基礎設施、資金籌措、檢體運輸以及專家的可用性。

按群體分析揭示的政策和准入優先事項差異

東南亞國協檢查室發展成熟度不一，但均受益於區域合作、聯合訓練和簡化的轉診系統。金磚國家成員國擁有相當的科學研究能力，但在經濟實力、採購和地理資源方面有顯著差異。歐盟強調品質、資料管治和跨境診斷標準的協調統一，而七國集團（G7）系統則普遍優先考慮證據生成、互通性和臨床效用。海灣合作理事會（GCC）國家正在投資建設先進的醫療基礎設施和集中化的專業技術。北約成員國的醫療體系各不相同，因此，建立具有韌性的供應鏈、建立通用的品管體係以及確保資料安全交換尤為重要。

各國具體實施考量因素

オーストラリアとカナダは、地理的な分散と、中央集権化された医療サービス全体における公平なアクセスへの対応が求められます。ブラジル、メキシコ、インドは、大規模かつ多様な患者集団を抱えており、紹介体制、経済的負担、檢查室の標準化が依然として重要な考慮事項となっています。中国、日本、韓国は、強力な臨床および研究能力を有していますが、規制の経路、調達構造、導入慣行において違いが見られます。フランス、ドイツ、イタリア、スペイン、および英國は、成熟した欧州の腫瘍学環境の中で運営されており、導入にあたっては各国の評価、償還、および檢查室の管治が影響を及ぼします。ロシアの診断環境は、国内の能力、調達条件、および専門技術へのアクセスによって形作られています。米国では、広範な検査能力がある一方で、保険者による補償範囲、検査経路、および臨床現場の実務にはばらつきが見られます。

分子診斷領域領導者應優先考慮的問題

產業領導者應針對相關檢體類型和具有臨床意義的突變檢驗檢測方法，透明地記錄分析性能，並設計能夠最大限度減少組織消耗和重複檢測的工作流程。他們還應與腫瘤網路和參考實驗室建立夥伴關係，投資於能力測試和人才培養，並準備證據，證明其不僅具備技術性能，而且具有臨床效用。區域策略應考慮監理差異、保險報銷實際情況、供應連續性、資料保護和公平取得。人工智慧驅動的功能應透過受控的檢驗、監控和明確的課責機制來實施。

調查方法執行摘要

本執行摘要涵蓋了指定的診斷類別和所需的地理分組。評估基於分子腫瘤診斷領域既定的考慮因素，包括生物標記的相關性、多重檢測、檢查室工作流程、法律規範、保險報銷、基礎設施、品管以及人工智慧的合理使用。區域、群體和國家的具體觀察結果均為定性且相對的，不包含市場估算、預測、市場佔有率、預期或公司特定聲明。營運決策應參考現行的司法管轄區臨床指南、監管文件、報銷政策和檢查室檢驗證據，以補充本摘要的結論。

結論：建立可靠、公正的生物標記檢測流程。

EGFR、KRAS、BRAF、PIK3CA、ALK 和 ROS1 等基因突變的多重檢測是精準腫瘤學的關鍵組成部分，但其影響並非僅取決於檢驗的可及性。可靠的實施需要經過驗證的性能、整合的臨床工作流程、專業的解讀、永續的品管系統以及患者公平的獲取途徑。那些能夠兼顧技術嚴謹性、在地化適應性和人工智慧合理應用的機構，將更有能力支援及時、具有臨床意義的分子層級決策。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：依技術分類

  • 數位PCR
  • 次世代定序
    • 標靶定序
    • 全EXOME定序
    • 全基因測序
  • 即時PCR
  • 桑格定序

第8章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：依癌症類型分類

  • 乳癌
  • 結腸癌
  • 肺癌
  • 黑色素瘤

第9章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：依樣本類型分類

  • 電漿
  • 組織

第10章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：依產品類型分類

  • 裝置
  • 試劑組

第11章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：依最終用戶分類

  • 學術研究機構
  • 診斷檢查室
  • 醫院和診所

第12章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：人類 EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 基因突變檢測試劑盒市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Amoy Diagnostics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biocartis NV
  • bioMerieux SA
  • EntroGen, Inc.
  • Illumina, Inc.
  • Pillar Biosciences, Inc.
  • QIAGEN NV
  • Roche Holding AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

第17章 主要專家

Product Code: MRR-3D150775E466

The Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market is projected to grow by USD 491.12 million at a CAGR of 10.43% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 245.12 million
Estimated Year [2026] USD 270.11 million
Forecast Year [2032] USD 491.12 million
CAGR (%) 10.43%

Human EGFR, KRAS, BRAF, PIK3CA, ALK, and ROS1 mutation detection kits support molecular characterization of tumors and help inform biomarker-guided clinical decision-making. Their relevance is strongest in oncology pathways where treatment selection, resistance assessment, and diagnostic confirmation depend on identifying actionable genomic alterations. Adoption is shaped by analytical performance, specimen quality, workflow integration, regulatory requirements, reimbursement, and access to trained laboratory personnel.

Transformative Shifts in Precision Oncology Diagnostics

The diagnostic landscape is shifting from single-gene testing toward multiplex and sequential testing strategies that improve tissue utilization and broaden biomarker coverage. Laboratories are also balancing tissue-based assays with liquid biopsy approaches, while emphasizing reproducibility, turnaround time, quality assurance, and compatibility with existing platforms. Companion-diagnostic alignment, decentralized testing, and clearer interpretation of complex variant results are becoming increasingly important as oncology care moves toward more individualized treatment pathways.

Artificial Intelligence Strengthens Interpretation and Workflow Efficiency

Artificial intelligence can improve this field by supporting image and signal interpretation, flagging quality-control anomalies, prioritizing variants, and helping laboratories manage workflow data. Its value depends on representative validation datasets, transparent performance measures, human oversight, cybersecurity, and compliance with applicable medical-device requirements. AI should augment-not replace-laboratory professionals, particularly when results are technically ambiguous or have significant treatment implications.

Regional Insights Across Global Diagnostic Systems

North America generally benefits from advanced molecular laboratories, established oncology networks, and structured biomarker testing pathways, although access and reimbursement can vary by jurisdiction. Europe combines strong research capacity with diverse national regulatory and funding environments. Asia-Pacific includes sophisticated testing ecosystems alongside rapidly expanding access needs, with infrastructure and workforce differences across markets. Latin America continues to face uneven availability of specialized testing and relies on referral networks in many settings. The Middle East is developing centralized and hospital-based molecular capabilities, while Africa's implementation is influenced by laboratory infrastructure, financing, specimen logistics, and specialist availability.

Group Insights Reveal Different Policy and Access Priorities

ASEAN economies show varied laboratory maturity and benefit from regional cooperation, shared training, and streamlined referral systems. BRICS members combine substantial scientific capabilities with pronounced differences in affordability, procurement, and geographic access. The European Union emphasizes harmonized quality, data governance, and cross-border diagnostic standards, while G7 systems generally prioritize evidence generation, interoperability, and clinical utility. GCC countries are investing in advanced healthcare infrastructure and centralized expertise. NATO members span diverse health systems, making resilient supply chains, common quality practices, and secure data exchange particularly relevant.

Country-Level Considerations for Implementation

Australia and Canada must address geographic dispersion and equitable access across centralized health services. Brazil, Mexico, and India face large and diverse patient populations, with referral capacity, affordability, and laboratory standardization remaining important considerations. China, Japan, and South Korea have strong clinical and research capabilities but differ in regulatory pathways, procurement structures, and adoption practices. France, Germany, Italy, Spain, and the United Kingdom operate within mature European oncology environments, with implementation influenced by national assessment, reimbursement, and laboratory governance. Russia's diagnostic environment is shaped by domestic capacity, procurement conditions, and access to specialized technologies. In the United States, broad laboratory capability coexists with variation in payer coverage, testing pathways, and clinical-site practices.

Action Priorities for Leaders in Molecular Diagnostics

Industry leaders should validate assays across relevant specimen types and clinically important variants, document analytical performance transparently, and design workflows that minimize tissue consumption and repeat testing. They should build partnerships with oncology networks and reference laboratories, invest in proficiency testing and workforce development, and prepare evidence that demonstrates clinical utility rather than technical performance alone. Regional strategies should account for regulatory differences, reimbursement realities, supply continuity, data protection, and equitable access. AI-enabled features should be introduced through controlled validation, monitoring, and clear accountability mechanisms.

Research Methodology for the Executive Summary

This executive summary uses the specified diagnostic category and required geographic groupings as its analytical scope. The assessment is structured around established considerations in molecular oncology diagnostics, including biomarker relevance, multiplex testing, laboratory workflow, regulatory oversight, reimbursement, infrastructure, quality management, and responsible AI use. Regional, group, and country observations are qualitative and comparative; no market estimates, shares, forecasts, or company-specific claims are included. Conclusions should be supplemented with current jurisdiction-level clinical guidelines, regulatory documents, reimbursement policies, and laboratory validation evidence before operational decisions are made.

Conclusion: Building Reliable, Equitable Biomarker Testing Pathways

Multiplex detection of EGFR, KRAS, BRAF, PIK3CA, ALK, and ROS1 alterations is an important component of precision oncology, but its impact depends on more than assay availability. Reliable implementation requires validated performance, integrated clinical workflows, skilled interpretation, sustainable quality systems, and equitable patient access. Organizations that combine technical rigor with regional adaptation and responsible use of artificial intelligence will be better positioned to support timely, clinically meaningful molecular decisions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital Pcr
  • 7.3. Next Gen Sequencing
    • 7.3.1. Targeted Sequencing
    • 7.3.2. Whole Exome Sequencing
    • 7.3.3. Whole Genome Sequencing
  • 7.4. Real Time Pcr
  • 7.5. Sanger Sequencing

8. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Cancer Type

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Colorectal Cancer
  • 8.4. Lung Cancer
  • 8.5. Melanoma

9. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Sample Type

  • 9.1. Introduction
  • 9.2. Blood Plasma
  • 9.3. Tissue

10. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Product Type

  • 10.1. Introduction
  • 10.2. Instruments
  • 10.3. Reagent Kits

11. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by End User

  • 11.1. Introduction
  • 11.2. Academic And Research Institutes
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals And Clinics

12. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories, Inc.
  • 16.2. Agilent Technologies, Inc.
  • 16.3. Amoy Diagnostics Co., Ltd.
  • 16.4. Bio-Rad Laboratories, Inc.
  • 16.5. Biocartis NV
  • 16.6. bioMerieux SA
  • 16.7. EntroGen, Inc.
  • 16.8. Illumina, Inc.
  • 16.9. Pillar Biosciences, Inc.
  • 16.10. QIAGEN N.V.
  • 16.11. Roche Holding AG
  • 16.12. Sysmex Corporation
  • 16.13. Thermo Fisher Scientific, Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Years Considered for the Study
  • FIGURE 2. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Research Design
  • FIGURE 3. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Research Framework
  • FIGURE 4. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Data Triangulation
  • FIGURE 5. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 7. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2025 vs 2032 (%)
  • FIGURE 11. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 13. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Segmentation & Coverage
  • TABLE 2. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 4. Global Digital Pcr Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Digital Pcr Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Digital Pcr Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Next Gen Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Next Gen Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Next Gen Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Whole Exome Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Whole Exome Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Whole Exome Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Real Time Pcr Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Real Time Pcr Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Real Time Pcr Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Sanger Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Sanger Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Sanger Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 26. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Melanoma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Melanoma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Melanoma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 39. Global Blood Plasma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Blood Plasma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Blood Plasma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 46. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Reagent Kits Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Reagent Kits Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Reagent Kits Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 53. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 69. Asia-Pacific Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 70. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 72. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 73. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 74. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 75. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 76. North America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 77. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 79. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 80. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 81. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 82. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 83. Latin America Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 84. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 86. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 87. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 88. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 89. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 90. Europe Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 91. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 93. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 94. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 95. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 96. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 97. Middle East Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 98. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 100. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 101. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 102. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 103. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 104. Africa Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 105. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 108. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 109. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 112. ASEAN Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 113. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 114. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 115. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 116. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 117. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 118. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 119. GCC Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 120. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 122. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 123. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 124. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 125. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 126. European Union Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 127. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 128. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 129. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 130. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 131. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 132. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 133. BRICS Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 134. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 136. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 137. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 138. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 139. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 140. G7 Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 141. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 142. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 143. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 144. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 145. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 146. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 147. NATO Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 149. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 150. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 151. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 152. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 153. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 154. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 155. United States Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 157. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 158. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 159. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 160. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 161. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 162. Canada Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 163. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 164. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 165. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 166. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 167. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 168. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 169. Mexico Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 170. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 171. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 172. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 173. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 174. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 175. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 176. Brazil Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 177. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 178. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 179. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 180. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 181. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 182. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 183. United Kingdom Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 184. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 185. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 186. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 187. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 188. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 189. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 190. Germany Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 191. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 192. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 193. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 194. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 195. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 196. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 197. France Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 198. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 199. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 200. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 201. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 202. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 203. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 204. Russia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 205. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 206. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 207. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 208. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 209. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 210. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 211. Italy Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 212. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 213. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 214. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 215. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 216. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 217. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 218. Spain Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 219. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 220. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 221. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 222. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 223. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 224. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 225. China Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 226. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 227. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 228. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 229. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 230. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 231. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 232. India Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 234. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 235. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 236. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 237. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 238. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 239. Japan Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 240. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 241. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 242. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 243. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 244. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 245. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 246. Australia Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 247. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, 2017-2032 (USD Million)
  • TABLE 248. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 249. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Next Gen Sequencing, 2017-2032 (USD Million)
  • TABLE 250. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Cancer Type, 2017-2032 (USD Million)
  • TABLE 251. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 252. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 253. South Korea Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 254. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market Share, by Key Player, 2025
  • TABLE 255. Global Human EGFR/KRAS/BRAF/PIK3CA/ALK/ROS1 Gene Mutation Detection Kit Market, Key Experts